Latest filing published 22 Jul 2016 for Immune Therapeutics, Inc..
Insider track record
No signal scores available.
Christopher Pearce: trading record in brief
Christopher Pearce is a declared insider of Immune Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 30 September 2014 and 18 July 2016, the trades on record add up to 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 22 July 2016, reports a transaction in Immune Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher Pearce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares0Common StockSEC:0001611650-16-000006:0
- 200,000 shares0COMMON STOCKSEC:0001264931-15-000089:0
- 500,000 shares0Common StockSEC:0001264931-14-000436:0
3 of 3 declarations